Termin vereinbaren
Verifizierte Patientenbewertungen des DCDC Diagnosezentrum in Dubai
Verifizierte Bewertungen und echte Patientenberichte aus Dubai Healthcare City
Ich bin sehr zufrieden mit dieser medizinischen Klinik. Ich hatte hier mein erstes Schwangerschaftsscreening. Es war erschwinglich und sehr professionell. Der Radiologe war einladend, freundlich und machte die Erfahrung großartig.
Aizhan Tokmanbetova
Am Freitagabend habe ich mir das Knie verletzt und am Sonntagabend einen MRT-Termin bekommen (am Sonntagnachmittag gebucht). Ich habe etwa 2 Minuten gewartet und war in etwas mehr als 30 Minuten fertig. Das Team war erstaunlich, freundlich und effizient.
Kirsten Evans
Das Team von Dr. Osama war sanft und erstaunlich. Nach einer schlechten Erfahrung anderswo war meine Beckenuntersuchung hier viel professioneller. Toller Bericht und sehr präzise.
Mary
CA-125 Blood Test in Dubai: Ovarian Cancer Marker Screening and Monitoring
Accurate CA-125 testing for ovarian cancer risk assessment, pelvic symptom evaluation, and treatment response monitoring
Precise Measurement
Advanced immunoassay for accurate CA-125 quantification
Clinical Context
Results interpreted by gynaecologists within your full health profile
Fast Results
Most CA-125 results available within 24-48 hours
Specialist Pathway
Direct referral to gynaecology for abnormal findings and further evaluation
CA-125, or Cancer Antigen 125, is a protein biomarker that is elevated in the blood of many women with ovarian cancer. Ovarian cancer is often called the silent killer because it typically presents with vague, non-specific symptoms that are easily attributed to other conditions, and by the time it is diagnosed, the disease has frequently advanced to later stages where treatment outcomes are less favourable. The CA-125 blood test, when used appropriately in the right clinical context, serves as a valuable tool for risk assessment, diagnostic support, treatment monitoring, and recurrence detection. Understanding both its strengths and limitations is essential for informed healthcare decisions.
At DCDC, we offer CA-125 testing as both a standalone marker and as part of comprehensive panels for women's health evaluation. The test measures the concentration of CA-125 protein in the blood, with levels below 35 units per millilitre generally considered normal. However, CA-125 is not exclusively produced by ovarian cancer cells. It is also found on the surface of normal cells in the fallopian tubes, endometrium, peritoneum, pleura, and pericardium, which means that various benign conditions can also cause elevations. This dual nature makes clinical interpretation essential and is why CA-125 should always be evaluated by a qualified physician within the full clinical context.
Precise Measurement
Advanced immunoassay for accurate CA-125 quantification
Clinical Context
Results interpreted by gynaecologists within your full health profile
Fast Results
Most CA-125 results available within 24-48 hours
Specialist Pathway
Direct referral to gynaecology for abnormal findings and further evaluation
CA-125 Blood Test in Dubai: Ovarian Cancer Marker Screening and Monitoring
Accurate CA-125 testing for ovarian cancer risk assessment, pelvic symptom evaluation, and treatment response monitoring
CA-125, or Cancer Antigen 125, is a protein biomarker that is elevated in the blood of many women with ovarian cancer. Ovarian cancer is often called the silent killer because it typically presents with vague, non-specific symptoms that are easily attributed to other conditions, and by the time it is diagnosed, the disease has frequently advanced to later stages where treatment outcomes are less favourable. The CA-125 blood test, when used appropriately in the right clinical context, serves as a valuable tool for risk assessment, diagnostic support, treatment monitoring, and recurrence detection. Understanding both its strengths and limitations is essential for informed healthcare decisions.
At DCDC, we offer CA-125 testing as both a standalone marker and as part of comprehensive panels for women's health evaluation. The test measures the concentration of CA-125 protein in the blood, with levels below 35 units per millilitre generally considered normal. However, CA-125 is not exclusively produced by ovarian cancer cells. It is also found on the surface of normal cells in the fallopian tubes, endometrium, peritoneum, pleura, and pericardium, which means that various benign conditions can also cause elevations. This dual nature makes clinical interpretation essential and is why CA-125 should always be evaluated by a qualified physician within the full clinical context.
Dr. Hadi Komshi
Unsere CA-125 Test Leistungen
Umfassende ca-125 test Leistungen im DCDC Dubai Healthcare City.
CA-125 Screening
Ovarian cancer marker blood test for risk assessment and symptom evaluation.
CA-125 Monitoring
Serial testing for treatment response tracking and recurrence surveillance.
Pelvic Mass Evaluation
CA-125 combined with ultrasound findings for ovarian mass risk stratification.
Women's Cancer Screening Panel
CA-125 alongside other relevant markers for comprehensive women's cancer assessment.
Alle Leistungen werden von DHA-lizenzierten Spezialisten durchgeführt
Für wen ist CA-125 Test geeignet?
CA-125 testing is recommended for women with symptoms suggestive of ovarian pathology, those with significant family history of ovarian or breast cancer, and patients requiring treatment monitoring for diagnosed ovarian cancer or endometriosis.
Persistent bloating lasting more than two weeks without clear cause
Pelvic or abdominal pain that is new, persistent, or unexplained
Difficulty eating or feeling full quickly with unexplained weight changes
Urinary urgency or frequency without urinary tract infection
Family history of ovarian, breast, or endometrial cancer
Known BRCA1 or BRCA2 gene mutation carriers
Ihr angenehmer Besuch
Ein einfacher, schrittweiser CA-125-Untersuchungsprozess für Komfort, Schnelligkeit und Genauigkeit.
Test Pricing
Die CA-125-Preise in Dubai variieren je nach Leistungsart und Versicherungsdeckung für verschiedene Testtypen.
- Preise variieren je nach Untersuchungsart und Kontrastmittelbedarf
- Versicherungsdeckung akzeptiert mit Überweisung und Verifizierung
- Transparente Selbstzahlerpreise mit sofortigem Angebot auf Anfrage
Versicherungsverifizierung in Minuten • Keine versteckten Gebühren • Schnelle Antwort auf WhatsApp
Patientenratgeber
Your Lab Test Experience
Quick, comfortable, and straightforward.
Versicherung & Standort
Versicherungspartner
- •Über 20 Versicherungsanbieter in Dubai einschließlich Daman, AXA, ADNIC und andere
- •Vorabgenehmigung-Unterstützung und Direktabrechnung (falls zutreffend)
- •Deckungsüberprüfung vor Ihrem Termin in unserer Klinik in Dubai Healthcare City
- •Transparente Preisgestaltung ohne versteckte Gebühren für ca-125 test-Leistungen
Besuchen Sie uns in Dubai Healthcare City
Doctors Clinic Diagnostic Center
Gebäude 64, Block A, Al Razi Medical Complex, Dubai Healthcare City, Dubai, VAE
Nahe der Oud Metha Road · Einfacher Zugang von Bur Dubai, Downtown Dubai, Business Bay · Kostenlose Patientenparkplätze verfügbar
Öffnungszeiten
Mo-Do, Sa: 8:00 - 22:30 Uhr | So: 8:30 - 22:30 Uhr | Fr: 9:00 - 22:00 Uhr
So funktioniert die Versicherung bei DCDC
Deckung prüfen
Überprüfen Sie, ob Ihr Plan CA-125 Test abdeckt
Überweisung erhalten
Einige Versicherer verlangen eine Überweisung — wir helfen Ihnen gerne
Vorab-Genehmigung
Wir übernehmen die Vorab-Genehmigung direkt mit Ihrem Versicherer
Direktabrechnung
Keine Vorauszahlung — wir rechnen direkt mit Ihrem Versicherer ab
Nur Eigenanteil
Sie zahlen nur den anfallenden Eigenanteil in der Klinik
Deckung prüfen
Überprüfen Sie, ob Ihr Plan CA-125 Test abdeckt
Überweisung erhalten
Einige Versicherer verlangen eine Überweisung — wir helfen Ihnen gerne
Vorab-Genehmigung
Wir übernehmen die Vorab-Genehmigung direkt mit Ihrem Versicherer
Direktabrechnung
Keine Vorauszahlung — wir rechnen direkt mit Ihrem Versicherer ab
Nur Eigenanteil
Sie zahlen nur den anfallenden Eigenanteil in der Klinik
Ihr Spezialist
Dr. Hadi Komshi
Specialist Internal Medicine
MD, Specialist Internal Medicine
Persisch · Arabisch · Englisch
Conditions and Cancers Assessed Through CA-125 Testing
Epithelial Ovarian Cancer
The most common type of ovarian cancer, with CA-125 elevated in approximately 80 percent of advanced cases and 50 percent of early-stage disease.
Fallopian Tube Cancer
Primary fallopian tube carcinoma, now recognised as closely related to high-grade serous ovarian cancer, with similar CA-125 elevation patterns.
Primary Peritoneal Cancer
Peritoneal carcinomatosis arising from peritoneal surfaces, sharing histology and CA-125 marker behaviour with epithelial ovarian cancer.
Endometriosis
Chronic pelvic condition frequently causing CA-125 elevation proportional to disease severity, useful for monitoring treatment response.
Verwandte Leistungen
Entdecken Sie weitere Diagnose- und Beratungsleistungen in unserer Klinik in Dubai Healthcare City.
Häufig gestellte Fragen
Häufige Fragen zu CA-125 Test in Dubai.
CA-125 is a glycoprotein normally expressed on cells lining the ovaries, fallopian tubes, endometrium, and peritoneum. Ovarian cancer cells produce significantly increased quantities, causing blood levels to rise above the normal threshold of 35 U/mL.
Yes, very commonly. In premenopausal women, 90 percent of CA-125 elevations are benign.
No. Major guidelines do not recommend CA-125 for general population screening due to limited sensitivity for early-stage cancer and high false-positive rates in premenopausal women.
During chemotherapy, declining CA-125 correlates with tumour response; normalization below 35 U/mL is associated with improved survival. CA-125 half-life below 14 days predicts better outcomes.
CA-125 is frequently elevated in endometriosis, correlating with disease severity. Mild disease may cause modest increases to 35-50 U/mL; severe disease with endometriomas can exceed 100-200 U/mL.
Wichtige Fakten
Medizinische Aufsicht
Alle Leistungen werden unter Aufsicht lizenzierter medizinischer Fachkräfte in unserer MOHAP-akkreditierten Einrichtung erbracht.